Literature DB >> 32539912

Preventing Dengue Epidemics during the COVID-19 Pandemic.

Annelies Wilder-Smith1, Hasitha Tissera2, Eng Eong Ooi3, Josefina Coloma4, Thomas W Scott5, Duane J Gubler3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32539912      PMCID: PMC7410414          DOI: 10.4269/ajtmh.20-0480

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
The COVID-19 pandemic is placing immense pressure on healthcare and public health systems worldwide. In addition to the COVID-19–related death toll and increased demand on intensive care, the pandemic has major repercussions on health outcomes of other diseases at times when resources and personnel are diverted to COVID-19. This challenge is of particular concern for low- and middle-income countries. WHO has emphasized the need to sustain efforts to prevent, detect, and treat vector-borne diseases, such as malaria, during this pandemic.[1] A similar approach should be adopted for the prevention and control of dengue and other arboviral diseases. About 100 million dengue cases occur every year, with the highest burden in Southeast Asia followed by Latin America.[2] Epidemic transmission of both dengue and COVID-19 is driven by population densities.[2,3] Thus, the impact of combined dengue and COVID-19 epidemics could have potentially devastating consequences in tropical and subtropical cities. Manifestations of this double burden are seen in Guayaquil, Ecuador, and Iquitos, Peru, where an enormous dengue season coincided with the spread of SARS-CoV-2, and extreme excess mortality cannot be attributed only to COVID-19.[4] The dengue incidence rate was 12.86 cases/100,000 inhabitants in the region for the ongoing year, including 27 deaths, 12,891 cases confirmed by laboratory, and 498 cases classified as severe dengue (0.4%).[4] Countries such as Bolivia, Honduras, Mexico and Paraguay have reported an increase of double or triple the number of cases of dengue compared with the same period from the previous year,[5] and the humanitarian and migration crisis in Venezuela has led to a breakdown in public health structures.[6] Southeast Asia is also battling a surge in dengue cases. In the early stages, dengue and COVID-19 are difficult to distinguish because they share similar clinical and laboratory features early on. Both often initially present as undifferentiated fever with nonspecific signs and symptoms; shared laboratory parameters include lymphopenia, leukopenia, thrombocytopenia, and elevated transaminases.[7] Singapore reported on patients being first incorrectly diagnosed with dengue due to a false-positive dengue rapid serological test who were later confirmed to be COVID-19.[7] Misdiagnosis of COVID-19 as dengue with failure to isolate such patients will trigger outbreaks in healthcare settings and beyond. Failing to recognize dengue and institute timely hydration may lead to preventable dengue-related deaths. High awareness of dengue and application of virological tests to differentiate dengue from COVID-19 is thus a priority in healthcare systems throughout the tropics and subtropics. At the same time, universal personal protective measures need to be applied at all times to prevent inadvertent SARS-CoV-2 transmission in healthcare centers. Although severe outcomes for COVID-19 appear to be predominantly in older persons,[8] whereas dengue affects more children and young adults in most dengue-endemic countries,[2] dengue has also emerged to be a major cause of morbidity and mortality in the elderly in places such as Singapore and Taiwan. A detailed and strict triage algorithm to differentiate the diseases should be followed. Coinfection with both viruses is possible and needs to be excluded. Although public health staff in many countries are currently diverted to COVID-19 response, it is of utmost importance to maintain and enhance mosquito control measures during the pandemic. For countries where governments have introduced lockdowns, special permissions should be sought to continue vector control strategies. Vector control teams targeting mosquito breeding sites should comply with social distancing measures and wear personal protective equipment (PPE) if entering houses for indoor residual insecticide spraying. Wearing PPE in hot and humid climates is cumbersome. The international community needs to develop new PPE approaches that are more amenable to such climates. Teams conducting indoor residual spraying at the household level could combine this activity with active case detection for COVID-19. Health messaging to enhance compliance to COVID-19 public health measures should be combined with messaging to enhance household and community participation in vector control measures. At a time of lockdowns when people are told to stay at home, community participation in mosquito control activities should be strengthened. Dengue transmission in and around homes is considered a driving factor for dengue outbreaks. Residents should be reminded of the mosquito life cycle, including the aquatic phase of 6–10 days, and encouraged to work together in and around their homes to remove stagnant water, reduce solid waste and plastics that fill with rain, and ensure proper covering of all water storage containers. The intra-domicile application of targeted indoor residual spraying should be selectively directed at Aedes aegypti resting places, such as under furniture and on dark surfaces. Precautions must be taken not to fumigate drinking water storage tanks. Tackling breeding sites at homes could become a weekly family activity that should be maintained even after lockdowns are lifted. Vulnerable members within households such as the elderly, pregnant women, infants, and those with underlying medical conditions should be encouraged to use insect repellents to protect themselves against mosquito bites. New innovative strategies could be developed; for example, to combine hand sanitizers against COVID-19 with insect repellents against arboviral diseases vectors. Studies have shown that buildings and sites beyond the household level can be at increased risk for breeding and proliferation of mosquitoes if no one takes ownership for vector control at those sites.[9] This is particularly true for schools, cemeteries, and construction sites.[9,10] Many lockdowns include school closures. It is important to maintain vector control measures at such schools even during closures to keep breeding sites at bay to prevent dengue outbreaks when children return to school after the lockdown. Regular cleaning and fumigation need to be maintained at construction sites and cemeteries even when regular work has been discontinued because of lockdown. In summary, a resurgence of dengue and other arboviral diseases is a real threat during the COVID-19 pandemic because they add to overwhelming already fragile healthcare systems. Lockdown periods should be leveraged as an opportunity to enhance vector control measures at the household level. At the community level, public health messaging and community engagement should include both diseases. At national and global levels, it is imperative to sustain effective vector control measures.
  9 in total

Review 1.  Dengue.

Authors:  Annelies Wilder-Smith; Eng-Eong Ooi; Olaf Horstick; Bridget Wills
Journal:  Lancet       Date:  2019-01-26       Impact factor: 79.321

2.  High population densities catalyse the spread of COVID-19.

Authors:  Joacim Rocklöv; Henrik Sjödin
Journal:  J Travel Med       Date:  2020-05-18       Impact factor: 8.490

3.  Characteristics of and factors associated with dengue vector breeding sites in the City of Colombo, Sri Lanka.

Authors:  Valérie R Louis; Carlos Alberto Montenegro Quiñonez; Pad Kusumawathie; Paba Palihawadana; Sakoo Janaki; Yesim Tozan; Ruwan Wijemuni; Annelies Wilder-Smith; Hasitha A Tissera
Journal:  Pathog Glob Health       Date:  2016-03       Impact factor: 2.894

4.  Infectious disease implications of large-scale migration of Venezuelan nationals.

Authors:  Ashleigh R Tuite; Andrea Thomas-Bachli; Hernan Acosta; Deepit Bhatia; Carmen Huber; Kieran Petrasek; Alexander Watts; Jean H E Yong; Isaac I Bogoch; Kamran Khan
Journal:  J Travel Med       Date:  2018-01-01       Impact factor: 8.490

5.  COVID-19 in Latin America: The implications of the first confirmed case in Brazil.

Authors:  Alfonso J Rodriguez-Morales; Viviana Gallego; Juan Pablo Escalera-Antezana; Claudio A Méndez; Lysien I Zambrano; Carlos Franco-Paredes; Jose A Suárez; Hernan D Rodriguez-Enciso; Graciela Josefina Balbin-Ramon; Eduardo Savio-Larriera; Alejandro Risquez; Sergio Cimerman
Journal:  Travel Med Infect Dis       Date:  2020-02-29       Impact factor: 6.211

6.  COVID-19 Mitigation Steps Provide a Blueprint for Malaria Control and Elimination.

Authors:  Manju Rahi; Payal Das; Amit Sharma
Journal:  Am J Trop Med Hyg       Date:  2020-05-07       Impact factor: 2.345

7.  Construction sites as an important driver of dengue transmission: implications for disease control.

Authors:  Shaohong Liang; Hapuarachchige Chanditha Hapuarachchi; Jayanthi Rajarethinam; Carmen Koo; Choon-Siang Tang; Chee-Seng Chong; Lee-Ching Ng; Grace Yap
Journal:  BMC Infect Dis       Date:  2018-08-08       Impact factor: 3.090

8.  Covert COVID-19 and false-positive dengue serology in Singapore.

Authors:  Gabriel Yan; Chun Kiat Lee; Lawrence T M Lam; Benedict Yan; Ying Xian Chua; Anita Y N Lim; Kee Fong Phang; Guan Sen Kew; Hazel Teng; Chin Hong Ngai; Li Lin; Rui Min Foo; Surinder Pada; Lee Ching Ng; Paul Anantharajah Tambyah
Journal:  Lancet Infect Dis       Date:  2020-03-04       Impact factor: 25.071

9.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

  9 in total
  21 in total

1.  Impact of sars-cov-2 interventions on dengue transmission.

Authors:  Jue Tao Lim; Borame Sue Lee Dickens; Lawrence Zheng Xiong Chew; Esther Li Wen Choo; Joel Ruihan Koo; Joel Aik; Lee Ching Ng; Alex R Cook
Journal:  PLoS Negl Trop Dis       Date:  2020-10-29

2.  Diagnostic Laboratory Testing and Clinical Preparedness for Dengue Outbreaks during the COVID-19 Pandemic.

Authors:  Stephen H Waterman; Gabriela Paz-Bailey; Jose L San Martin; Gamaliel Gutierrez; Luis G Castellanos; Jairo A Mendez-Rico
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 2.345

Review 3.  What Is the Impact of Lockdowns on Dengue?

Authors:  Oliver Brady; Annelies Wilder-Smith
Journal:  Curr Infect Dis Rep       Date:  2021-01-21       Impact factor: 3.663

4.  Impact of concurrent epidemics of dengue, chikungunya, zika, and COVID-19.

Authors:  Creuza Rachel Vicente; Theresa Cristina Cardoso da Silva; Larissa Dell'Antonio Pereira; Angelica E Miranda
Journal:  Rev Soc Bras Med Trop       Date:  2021-02-26       Impact factor: 1.581

5.  Experience of a Tertiary Hospital in Singapore with Management of a Dual Outbreak of COVID-19 and Dengue.

Authors:  Liang En Wee; Benjamin Pei Zhi Cherng; Edwin Philip Conceicao; Kenneth Choon-Meng Goh; Wei Yee Wan; Kwan Ki Karrie Ko; May Kyawt Aung; Xiang Ying Jean Sim; Limin Wijaya; Moi Lin Ling; Indumathi Venkatachalam
Journal:  Am J Trop Med Hyg       Date:  2020-11       Impact factor: 2.345

6.  The COVID-19 pandemic should not jeopardize dengue control.

Authors:  Marie-Marie Olive; Thierry Baldet; James Devillers; Johanna Fite; Marie-Claire Paty; Christophe Paupy; Philippe Quénel; Elsa Quillery; Jocelyn Raude; Jean-Paul Stahl; Marie Thiann-Bo-Morel; David Roiz
Journal:  PLoS Negl Trop Dis       Date:  2020-09-23

7.  The COVID-19 pandemic should not derail global vector control efforts.

Authors:  Frederik Seelig; Haroldo Bezerra; Mary Cameron; Jeffrey Hii; Alexandra Hiscox; Seth Irish; Robert T Jones; Trudie Lang; Steven W Lindsay; Rachel Lowe; Tanaka Manikidza Nyoni; Grace M Power; Juliana Quintero; Anna M Stewart-Ibarra; Lucy S Tusting; Scott Tytheridge; James G Logan
Journal:  PLoS Negl Trop Dis       Date:  2020-08-31

Review 8.  Covid-19 and dengue: Double punches for dengue-endemic countries in Asia.

Authors:  Harapan Harapan; Mirza Ryan; Benediktus Yohan; Rufika Shari Abidin; Firzan Nainu; Ahmed Rakib; Israt Jahan; Talha Bin Emran; Irfan Ullah; Kritu Panta; Kuldeep Dhama; R Tedjo Sasmono
Journal:  Rev Med Virol       Date:  2020-09-18       Impact factor: 11.043

Review 9.  Dengue vaccine development by the year 2020: challenges and prospects.

Authors:  Annelies Wilder-Smith
Journal:  Curr Opin Virol       Date:  2020-10-18       Impact factor: 7.090

10.  COVID-19 and arboviral diseases: Another challenge for Pakistan's dilapidated healthcare system.

Authors:  Usman A Awan; Sarmad Zahoor; Ayesha Ayub; Haroon Ahmed; Nauman Aftab; Muhammad S Afzal
Journal:  J Med Virol       Date:  2020-12-01       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.